Phase I Study of CCI-779 (NSC 683864, IND 61010) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumours
Phase of Trial: Phase I
Latest Information Update: 21 Mar 2016
At a glance
- Drugs Temsirolimus (Primary) ; Carboplatin; Paclitaxel
- Indications Endometrial cancer; Ovarian cancer; Solid tumours
- Focus Adverse reactions
- 08 Aug 2011 Planned end date changed from 1 Apr 2009 to 1 Nov 2011 as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Jan 2009 Status changed from suspended to recruiting according to both the ClinicalTrials.gov record and the National Cancer Institute of Canada record.